The Allo- and Viral-Specific Immunosuppressive Effect of Belatacept, but Not Tacrolimus, Attenuates With Progressive T Cell Maturation

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

(2011) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression

(2010) D. J. Lo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

(2010) F. Vincenti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Allo-HLA reactivity of virus-specific memory T cells is common

(2010) A. L. Amir et al.   BLOOD

LFA-1–specific therapy prolongs allograft survival in rhesus macaques

(2010) Idelberto R. Badell et al.   JOURNAL OF CLINICAL INVESTIGATION

Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation

(2009) H. Ekberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation

(2009) Nicolas C. Issa et al.   CLINICAL INFECTIOUS DISEASES

Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time

(2009) E. M. Iancu et al.   JOURNAL OF IMMUNOLOGY

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

(2009) Tim A Weaver et al.   NATURE MEDICINE

Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation

(2009) R.A. Fisher   Transplant Infectious Disease

Late Kidney Allograft Loss: What We Know about It, and What We Can Do about It

(2008) A. M. Jevnikar et al.   Clinical Journal of the American Society of Nephrology